2seventy bio
TSVT
TSVT was delisted on the 13th of May, 2025.
116 hedge funds and large institutions have $135M invested in 2seventy bio in 2024 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 34 increasing their positions, 26 reducing their positions, and 18 closing their positions.
418% more call options, than puts
Call options by funds: $57K | Put options by funds: $11K
31% more repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 26
22% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 18
1% more funds holding
Funds holding: 115 → 116 (+1)
36% less capital invested
Capital invested by funds: $213M → $135M (-$77.6M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$7.85M |
| 2 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
+$3.28M |
| 3 |
WSL
Western Standard LLC
Los Angeles,
California
|
+$2.06M |
| 4 |
BlackRock
New York
|
+$1.45M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$1.27M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MAP
Madison Avenue Partners
New York
|
-$8.14M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$3.93M |
| 3 |
ECM
Engine Capital Management
New York
|
-$2.4M |
| 4 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
-$1.27M |
| 5 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$824K |
TSVT Hedge Fund Activity: Q4 2024 in Review
116 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in 2seventy bio (TSVT) for Q4 2024, worth a combined $135M — down 36% from $213M a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new TSVT positions and 18 closed out — a net gain of 4 holders — while 34 added to existing stakes and 26 trimmed.
The largest buyer was Bank of America, adding an estimated $7.85M. The largest seller was Madison Avenue Partners, cutting an estimated $8.14M.
- 116 institutional investors held 2seventy bio (TSVT) as of Q4 2024, up from 115 in Q3 2024.
- Funds reported $135M of 2seventy bio stock for Q4 2024, down 36% quarter-over-quarter.
- 22 funds opened new 2seventy bio positions in Q4 2024 and 18 closed out, a net change of +4 holders.
- The largest 2seventy bio buyer in Q4 2024 was Bank of America, an estimated $7.85M added.
- The largest 2seventy bio seller in Q4 2024 was Madison Avenue Partners, an estimated $8.14M sold.
Based on aggregated 13F filings for Q4 2024.